Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

Clinical trial NCT02999633 · TERMINATED

Trial details

NCT number: NCT02999633
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia

Start date: 2017-03-08
Primary completion: 2017-11-14
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.